| Code | 8911D | ||||||||||
| MA number | 16/0276/21-S | ||||||||||
| Product Form: | tbl flm 200x5 mg (blis.Al/PVC/PVDC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 11.11.2021 |
| SPC: |
SPC_Apixaban Sandoz 5 mg_05.2024.pdf
|
| PIL: |
PIL_Apixaban Sandoz 5 mg_05.2024.pdf
|
| Dokument: |
Karta pacienta.pdf
|
| Dokument: |
Apixaban_Príručka pre lekára.pdf
|
| Safety feature | Yes |
| Data update: | 08.01.2026 |
